Pharmacogenetic analysis of clinically relevant genetic polymorphisms

Area of Science:

• Genetics
• Pharmacology
• Critical Care Medicine

Background:

• The human genome sequence enables gene-based medical approaches, particularly pharmacogenetics, which uses genetic profiles to tailor drug prescriptions.
• Pharmacogenetics leverages genetic variations like single-nucleotide polymorphisms (SNPs) to personalize medicine.
• While extensively studied for chronic diseases, pharmacogenomic applications in critical care for acute conditions remain underexplored.

Purpose of the Study:

• To explore the potential utility of pharmacogenomic methodology in guiding drug selection for acutely ill patients in the critical care environment.
• To highlight the theoretical benefits of pharmacogenomics for improving quality and outcomes in critical care settings.

Main Methods:

• Review of existing literature on pharmacogenetics and its application in various medical fields.
• Analysis of the current state of pharmacogenomic research concerning acute care and critical illness.

Main Results:

• Pharmacogenetics offers a promising avenue for optimizing drug therapy by considering individual genetic makeup.
• Significant interest exists in applying pharmacogenetics to chronic conditions like cancer and cardiovascular disease.
• Limited research and practical application have been dedicated to pharmacogenomics in the critical care setting for acute illnesses.

Conclusions:

• Pharmacogenomic approaches hold theoretical appeal for enhancing patient care and outcomes in critical care.
• Current obstacles impede the widespread clinical application of pharmacogenetics in managing acutely ill patients.
• Further research and development are necessary to overcome challenges and realize the full potential of pharmacogenomics in critical care medicine.